SMTL ID : 5exl.1

FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-(aminomethyl)-~{N}-[(1~{S})-1-[4-(3-oxidanyl-1~{H}-indazol-5-yl)pyridin-2-yl]-2-phenyl-ethyl]cyclohexane-1-carboxamide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x 5SS: 4-(aminomethyl)-~{N}-[(1~{S})-1-[4-(3-oxidanyl-1~{H}-indazol-5-yl)pyridin-2-yl]-2-phenyl-ethyl]cyclohexane-1-carboxamide(Non-covalent)

5SS.1: 21 residues within 4Å: Chain A: R.26, H.27, L.28, C.29, H.44, C.45, Y.134, I.141, D.182, A.183, C.184, K.185, G.186, D.187, S.188, T.206, S.207, W.208, G.211, C.212 Ligands: EDO.10 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:L.28, A:I.141, A:K.185, A:T.206 Hydrogen bonds: A:R.26, A:H.27, A:Y.134, A:G.186, A:D.187, A:S.188, A:S.188, A:G.211 Water bridges: A:H.44, A:I.141, A:I.141 pi-Cation interactions: A:R.26

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 2 residues within 4Å: Chain A: R.161, R.177 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.161, A:R.177 SO4.3: 10 residues within 4Å: Chain A: S.7, V.8, R.9, G.10, E.11, W.12, P.13, I.61, L.62, L.145 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:G.10, A:W.12, A:W.12, A:I.61 Water bridges: A:G.60, A:I.61

7 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.4: 6 residues within 4Å: Chain A: N.36, T.102, V.103, G.104, Y.105 Ligands: EDO.8 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.36, A:Y.105 EDO.5: 6 residues within 4Å: Chain A: Q.64, S.65, I.141, Q.142, N.143 Ligands: EDO.10 No protein-ligand interaction detected (PLIP) EDO.6: 2 residues within 4Å: Chain A: R.9, L.62 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.9 Water bridges: A:N.63 EDO.7: 3 residues within 4Å: Chain A: T.168, H.169 Ligands: EDO.9 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:H.169 EDO.8: 3 residues within 4Å: Chain A: G.104, Y.105 Ligands: EDO.4 2 PLIP interactions: 2 interactions with chain A Water bridges: A:G.104, A:Y.105 EDO.9: 6 residues within 4Å: Chain A: S.90, G.91, Y.92, T.168, K.170 Ligands: EDO.7 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:S.90, A:Y.92, A:T.168 Water bridges: A:Y.92 EDO.10: 5 residues within 4Å: Chain A: R.26, H.27, I.141 Ligands: 5SS.1, EDO.5 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:H.27

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Corte, J.R. et al., Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group. Bioorg.Med.Chem. (2016)

Release Date

2016-04-13

Peptides

Coagulation factor XIa light chain: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Coagulation factor XIa light chain

Related Entries With Identical Sequence